OpenURL Connection Search

Select item for more details and to access through your institution.

MRD negativity: considerations for older adults with multiple myeloma.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00939-y
By:
- Mian, Hira;
- Wildes, Tanya M.;
- Venner, Christopher P.;
- Fonseca, Rafael
Publication type:
Article
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00905-8
By:
- Côté, Julie;
- LeBlanc, Richard;
- Mian, Hira;
- Chu, Michael P.;
- McCurdy, Arleigh;
- Masih-Khan, Esther;
- Su, Jiandong;
- Jimenez-Zepeda, Victor H.;
- Song, Kevin;
- Louzada, Martha;
- White, Darrell;
- Sebag, Michael;
- Reiman, Anthony;
- Stakiw, Julie;
- Kotb, Rami;
- Bergstrom, Debra;
- Aslam, Muhammad;
- Kaedbey, Rayan;
- Venner, Christopher P.;
- Gul, Engin
Publication type:
Article
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00888-6
By:
- McCurdy, Arleigh;
- Mian, Hira;
- LeBlanc, Richard;
- Jimenez-Zepeda, Victor H.;
- Su, Jiandong;
- Masih-Khan, Esther;
- Visram, Alissa;
- Louzada, Martha;
- Song, Kevin;
- White, Darrell;
- Sebag, Michael;
- Stakiw, Julie;
- Reiman, Anthony;
- Aslam, Muhammad;
- Bergstrom, Debra;
- Kotb, Rami;
- Kaedbey, Rayan;
- Gul, Engin;
- Reece, Donna;
- Venner, Christopher P.
Publication type:
Article
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00883-x
By:
- McCurdy, Arleigh;
- Mian, Hira;
- LeBlanc, Richard;
- Jimenez-Zepeda, Victor H.;
- Su, Jiandong;
- Masih-Khan, Esther;
- Visram, Alissa;
- Louzada, Martha;
- Song, Kevin;
- White, Darrell;
- Sebag, Michael;
- Stakiw, Julie;
- Reiman, Anthony;
- Aslam, Muhammad;
- Bergstrom, Debra;
- Kotb, Rami;
- Kaedbey, Rayan;
- Gul, Engin;
- Reece, Donna;
- Venner, Christopher P.
Publication type:
Article
Exploring participant perceptions of a virtually supported home exercise program for people with multiple myeloma using a novel eHealth application: a qualitative study.
Published in:
Supportive Care in Cancer, 2023, v. 31, n. 5, p. 1, doi. 10.1007/s00520-023-07762-y
By:
- Purdy, Graeme M.;
- Sobierajski, Frances M.;
- Al Onazi, Mona M.;
- Effa, Corrie J.;
- Venner, Christopher P.;
- Tandon, Puneeta;
- McNeely, Margaret L.
Publication type:
Article
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.
Published in:
Current Oncology, 2022, v. 29, n. 3, p. 1575, doi. 10.3390/curroncol29030132
By:
- McCurdy, Arleigh;
- Venner, Christopher P.;
- Masih-Khan, Esther;
- Louzada, Martha;
- LeBlanc, Richard;
- Sebag, Michael;
- Song, Kevin;
- Jimenez-Zepeda, Victor H.;
- Kotb, Rami;
- Kardjadj, Moustafa;
- Mian, Hira;
- White, Darrell;
- Stakiw, Julie;
- Aslam, Muhammad;
- Reiman, Anthony;
- Gul, Engin;
- Reece, Donna
Publication type:
Article
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
Published in:
British Journal of Haematology, 2022, v. 198, n. 1, p. 93, doi. 10.1111/bjh.18172
By:
- LeBlanc, Richard;
- Mian, Hira;
- Reece, Donna;
- Masih‐Khan, Esther;
- Kardjadj, Moustafa;
- Jimenez‐Zepeda, Victor H.;
- McCurdy, Arleigh;
- Song, Kevin;
- Sebag, Michael;
- Louzada, Martha;
- White, Darrell;
- Stakiw, Julie;
- Kotb, Rami;
- Reiman, Anthony;
- Aslam, Muhammad;
- Gul, Engin;
- Venner, Christopher P.
Publication type:
Article
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy.
Published in:
British Journal of Haematology, 2021, v. 194, n. 4, p. 784, doi. 10.1111/bjh.17541
By:
- Quach, Hang;
- Nooka, Ajay;
- Samoylova, Olga;
- Venner, Christopher P.;
- Kim, Kihyun;
- Facon, Thierry;
- Spencer, Andrew;
- Usmani, Saad Z.;
- Grosicki, Sebastian;
- Suzuki, Kenshi;
- Delimpasi, Sosana;
- Weisel, Katja;
- Obreja, Mihaela;
- Zahlten‐Kumeli, Anita;
- Mateos, Maria‐Victoria
Publication type:
Article
Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
Published in:
British Journal of Haematology, 2014, v. 166, n. 6, p. 842, doi. 10.1111/bjh.12973
By:
- Mahmood, Shameem;
- Venner, Christopher P.;
- Sachchithanantham, Sajitha;
- Lane, Thirusha;
- Rannigan, Lisa;
- Foard, Darren;
- Pinney, Jenny H.;
- Gibbs, Simon D. J.;
- Whelan, Carol J.;
- Lachmann, Helen J.;
- Gillmore, Julian D.;
- Hawkins, Philip N.;
- Wechalekar, Ashutosh D.
Publication type:
Article
Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
Published in:
British Journal of Haematology, 2014, v. 165, n. 5, p. 842, doi. 10.1111/bjh.12973
By:
- Mahmood, Shameem;
- Venner, Christopher P.;
- Sachchithanantham, Sajitha;
- Lane, Thirusha;
- Rannigan, Lisa;
- Foard, Darren;
- Pinney, Jenny H.;
- Gibbs, Simon D. J.;
- Whelan, Carol J.;
- Lachmann, Helen J.;
- Gillmore, Julian D.;
- Hawkins, Philip N.;
- Wechalekar, Ashutosh D.
Publication type:
Article
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosis.
Published in:
British Journal of Haematology, 2013, v. 162, n. 6, p. 856, doi. 10.1111/bjh.12433
By:
- Roussel, Murielle;
- Sachchithanantham, Sajitha;
- Gibbs, Simon D. J.;
- Venner, Christopher P.;
- Pinney, Jennifer H.;
- Gillmore, Julian D.;
- Lachmann, Helen J.;
- Hawkins, Philip N.;
- Wechalekar, Ashutosh D.
Publication type:
Article
Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study
Published in:
American Journal of Hematology, 2022, v. 97, n. 3, p. E83, doi. 10.1002/ajh.26434
By:
- Delimpasi, Sosana;
- Mateos, Maria Victoria;
- Auner, Holger W.;
- Gavriatopoulou, Maria;
- Dimopoulos, Meletios A.;
- Quach, Hang;
- Pylypenko, Halyna;
- Hájek, Roman;
- Leleu, Xavier;
- Dolai, Tuphan Kanti;
- Sinha, Dinesh Kumar;
- Venner, Christopher P.;
- Benjamin, Reuben;
- Garg, Mamta Krishnan;
- Doronin, Vadim;
- Levy, Yair;
- Moreau, Philippe;
- Chai, Yi;
- Arazy, Melina;
- Shah, Jatin
Publication type:
Article
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
Published in:
American Journal of Hematology, 2021, v. 96, n. 9, p. 1120, doi. 10.1002/ajh.26261
By:
- Richard, Shambavi;
- Chari, Ajai;
- Delimpasi, Sosana;
- Simonova, Maryana;
- Spicka, Ivan;
- Pour, Ludek;
- Kriachok, Iryna;
- Dimopoulos, Meletios A.;
- Pylypenko, Halyna;
- Auner, Holger W.;
- Leleu, Xavier;
- Usenko, Ganna;
- Hajek, Roman;
- Benjamin, Reuben;
- Dolai, Tuphan Kanti;
- Sinha, Dinesh Kumar;
- Venner, Christopher P.;
- Garg, Mamta;
- Stevens, Don Ambrose;
- Quach, Hang
Publication type:
Article
Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Published in:
American Journal of Hematology, 2021, v. 96, n. 6, p. 708, doi. 10.1002/ajh.26172
By:
- Auner, Holger W.;
- Gavriatopoulou, Maria;
- Delimpasi, Sosana;
- Simonova, Maryana;
- Spicka, Ivan;
- Pour, Ludek;
- Dimopoulos, Meletios A.;
- Kriachok, Iryna;
- Pylypenko, Halyna;
- Leleu, Xavier;
- Doronin, Vadim;
- Usenko, Ganna;
- Hajek, Roman;
- Benjamin, Reuben;
- Dolai, Tuphan Kanti;
- Sinha, Dinesh Kumar;
- Venner, Christopher P.;
- Garg, Mamta;
- Stevens, Don Ambrose;
- Quach, Hang
Publication type:
Article
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial.
Published in:
American Journal of Hematology, 2021, v. 96, n. 5, p. 552, doi. 10.1002/ajh.26147
By:
- Venner, Christopher P.;
- LeBlanc, Richard;
- Sandhu, Irwindeep;
- White, Darrell;
- Belch, Andrew R.;
- Reece, Donna E.;
- Chen, Christine;
- Dolan, Sean;
- Lalancette, Marc;
- Louzada, Martha;
- Kew, Andrea;
- McCurdy, Arleigh;
- Monteith, Bethany;
- Reiman, Tony;
- McDonald, Gail;
- Sherry, Max;
- Gul, Engin;
- Chen, Bingshu E.;
- Hay, Annette E.
Publication type:
Article
Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma
Published in:
PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064927
By:
- Kriangkum, Jitra;
- Motz, Sarah N.;
- Debes Marun, Carina S.;
- Lafarge, Sandrine T.;
- Gibson, Spencer B.;
- Venner, Christopher P.;
- Johnston, James B.;
- Belch, Andrew R.;
- Pilarski, Linda M.
Publication type:
Article
Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model.
Published in:
Cancers, 2018, v. 10, n. 6, p. 206, doi. 10.3390/cancers10060206
By:
- Huang, Yung-Hsing;
- Molavi, Ommoleila;
- Alshareef, Abdulraheem;
- Haque, Moinul;
- Wang, Qian;
- Chu, Michael P.;
- Venner, Christopher P.;
- Sandhu, Irwindeep;
- Peters, Anthea C.;
- Lavasanifar, Afsaneh;
- Lai, Raymond
Publication type:
Article
Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada.
Published in:
European Journal of Haematology, 2021, v. 107, n. 4, p. 416, doi. 10.1111/ejh.13678
By:
- Reece, Donna E.;
- Masih‐Khan, Esther;
- Atenafu, Ehetu G.;
- Jimenez‐Zepeda, Victor H.;
- McCurdy, Arleigh;
- Song, Kevin;
- LeBlanc, Richard;
- Sebag, Michael;
- White, Darrell;
- Cherniawsky, Hannah;
- Reiman, Anthony;
- Stakiw, Julie;
- Louzada, Martha L.;
- Kotb, Rami;
- Aslam, Muhammad;
- Gul, Engin;
- Venner, Christopher P.
Publication type:
Article
A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Published in:
European Journal of Haematology, 2021, v. 107, n. 3, p. 333, doi. 10.1111/ejh.13671
By:
- Monteith, Bethany E.;
- Venner, Christopher P.;
- Cheung, Matthew C.;
- Pater, Joe;
- Shepherd, Lois;
- Richardson, Harriet;
- Reece, Donna;
- Gul, Engin;
- Lalancette, Marc;
- Castonguay, Vincent;
- Kukreti, Vishal;
- Tiedemann, Rodger;
- Phua, Chai;
- Bhella, Sita;
- Dudebout, Jill;
- Sherry, Max;
- Yen, Hope;
- Chen, Bingshu E.;
- Hay, Annette E.
Publication type:
Article
The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma.
Published in:
European Journal of Haematology, 2021, v. 106, n. 5, p. 673, doi. 10.1111/ejh.13596
By:
- Cherniawsky, Hannah M.;
- Kukreti, Vishal;
- Reece, Donna;
- Masih‐Khan, Esther;
- McCurdy, Arleigh;
- Jimenez‐Zepeda, Victor H.;
- Sebag, Michael;
- Song, Kevin;
- White, Darrell;
- Stakiw, Julie;
- LeBlanc, Richard;
- Reiman, Anthony;
- Louzada, Martha;
- Aslam, Muhammad;
- Kotb, Rami;
- Gul, Engin;
- Atenafu, Eshetu;
- Venner, Christopher P.
Publication type:
Article
Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4357, doi. 10.1002/cam4.5245
By:
- Mian, Hira;
- LeBlanc, Richard;
- Louzada, Martha;
- Masih‐Khan, Esther;
- McCurdy, Arleigh;
- Venner, Christopher P.;
- Stakiw, Julie;
- Kardjadj, Moustafa;
- Jimenez‐Zepeda, Victor H.;
- Sebag, Michael;
- White, Darrell;
- Aslam, Muhammad;
- Song, Kevin;
- Reiman, Anthony;
- Kotb, Rami;
- Gul, Engin;
- Reece, Donna
Publication type:
Article
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.826342
By:
- Mian, Hira;
- Eisfeld, Christine;
- Venner, Christopher P.;
- Masih-Khan, Esther;
- Kardjadj, Moustafa;
- Jimenez-Zepeda, Victor H.;
- Khandanpour, Cyrus;
- Lenz, Georg;
- McCurdy, Arleigh;
- Sebag, Michael;
- Song, Kevin;
- LeBlanc, Richard;
- White, Darrell;
- Stakiw, Julie;
- Reiman, Anthony;
- Louzada, Martha;
- Aslam, Muhammad;
- Kotb, Rami;
- Gul, Engin;
- Reece, Donna
Publication type:
Article
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 608, doi. 10.1016/j.clml.2022.03.002
By:
- Mian, Hira;
- Reece, Donna;
- Masih-Khan, Esther;
- McCurdy, Arleigh;
- Kardjadj, Moustafa;
- Jimenez-Zepeda, Victor H;
- Song, Kevin;
- Louzada, Martha;
- LeBlanc, Richard;
- Sebag, Michael;
- White, Darrell;
- Stakiw, Julie;
- Reiman, Anthony;
- Kotb, Rami;
- Aslam, Muhammad;
- Gul, Engin;
- Venner, Christopher P.
Publication type:
Article
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
Published in:
2020
By:
- Monteith, Bethany E.;
- Venner, Christopher P.;
- Reece, Donna E.;
- Kew, Andrea K.;
- Lalancette, Marc;
- Garland, Jocelyn S.;
- Shepherd, Lois E.;
- Pater, Joseph L.;
- Hay, Annette E.
Publication type:
journal article
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium.
Published in:
2020
By:
- Bergstrom, Debra J.;
- Kotb, Rami;
- Louzada, Martha L.;
- Sutherland, Heather J.;
- Tavoularis, Sofia;
- Venner, Christopher P.;
- Myeloma Canada Research Network Consensus Guideline Consortium
Publication type:
journal article
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Published in:
2022
By:
- Gasparetto, Cristina;
- Schiller, Gary J;
- Tuchman, Sascha A;
- Callander, Natalie S;
- Baljevic, Muhamed;
- Lentzsch, Suzanne;
- Rossi, Adriana C;
- Kotb, Rami;
- White, Darrell;
- Bahlis, Nizar J;
- Chen, Christine I;
- Sutherland, Heather J;
- Madan, Sumit;
- LeBlanc, Richard;
- Sebag, Michael;
- Venner, Christopher P;
- Bensinger, William I;
- Biran, Noa;
- Ammu, Sonia;
- Ben-Shahar, Osnat
Publication type:
journal article
Part 7: Monoclonal gammopathy for the non-hematologist oncologist.
Published in:
Oncology Exchange, 2013, v. 12, n. 3, p. 15
By:
- Brigden, Malcolm;
- Venner, Christopher P.
Publication type:
Article
Systemic Amyloidosis in England: an epidemiological study.
Published in:
British Journal of Haematology, 2013, v. 161, n. 4, p. 525, doi. 10.1111/bjh.12286
By:
- Pinney, Jennifer H.;
- Smith, Colette J.;
- Taube, Jessi B.;
- Lachmann, Helen J.;
- Venner, Christopher P.;
- Gibbs, Simon D. J.;
- Dungu, Jason;
- Banypersad, Sanjay M.;
- Wechalekar, Ashutosh D.;
- Whelan, Carol J.;
- Hawkins, Philip N.;
- Gillmore, Julian D.
Publication type:
Article
Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data.
Published in:
Oncologist, 2020, v. 25, n. 8, p. 722, doi. 10.1634/theoncologist.2019-0384
By:
- Watanabe, Sharon M.;
- Faily, Viane;
- Mawani, Asifa;
- Huot, Ann;
- Tarumi, Yoko;
- Potapov, Alexei;
- Fassbender, Konrad;
- Fairchild, Alysa;
- Joy, Anil A.;
- King, Karen M.;
- Roa, Wilson;
- Venner, Christopher P.;
- Baracos, Vickie E.
Publication type:
Article
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Published in:
2021
By:
- Mateos, Maria V.;
- Gavriatopoulou, Maria;
- Facon, Thierry;
- Auner, Holger W.;
- Leleu, Xavier;
- Hájek, Roman;
- Dimopoulos, Meletios A.;
- Delimpasi, Sosana;
- Simonova, Maryana;
- Špička, Ivan;
- Pour, Ludĕk;
- Kriachok, Iryna;
- Pylypenko, Halyna;
- Doronin, Vadim;
- Usenko, Ganna;
- Benjamin, Reuben;
- Dolai, Tuphan K.;
- Sinha, Dinesh K.;
- Venner, Christopher P.;
- Garg, Mamta
Publication type:
Letter
Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database
Published in:
EJHaem, 2024, v. 5, n. 3, p. 474, doi. 10.1002/jha2.894
By:
- Kaedbey, Rayan;
- Reece, Donna;
- Venner, Christopher P.;
- McCurdy, Arleigh;
- Su, Jiandong;
- Chu, Michael;
- Louzada, Martha;
- Jimenez‐Zepeda, Victor H;
- Mian, Hira;
- Song, Kevin;
- Sebag, Michael;
- Stakiw, Julie;
- White, Darrell;
- Reiman, Anthony;
- Aslam, Muhammad;
- Kotb, Rami;
- Bergstrom, Debra;
- Gul, Engin;
- LeBlanc, Richard
Publication type:
Article
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.
Published in:
EJHaem, 2023, v. 4, n. 4, p. 995, doi. 10.1002/jha2.759
By:
- Richardson, Paul G.;
- Facon, Thierry;
- Venner, Christopher P.;
- Bahlis, Nizar J.;
- Offner, Fritz;
- White, Darrell;
- Karlin, Lionel;
- Benboubker, Lotfi;
- Voog, Eric;
- Yoon, Sung‐Soo;
- Suzuki, Kenshi;
- Shibayama, Hirohiko;
- Zhang, Xiaoquan;
- Villarreal, Miguel;
- Twumasi‐Ankrah, Philip;
- Labotka, Richard;
- Rifkin, Robert M.;
- Lonial, Sagar;
- Kumar, Shaji K.;
- Rajkumar, S. Vincent
Publication type:
Article
Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment.
Published in:
EJHaem, 2022, v. 3, n. 4, p. 1270, doi. 10.1002/jha2.572
By:
- Baljevic, Muhamed;
- Gasparetto, Cristina;
- Schiller, Gary J.;
- Tuchman, Sascha A.;
- Callander, Natalie S.;
- Lentzsch, Suzanne;
- Monge, Jorge;
- Kotb, Rami;
- Bahlis, Nizar J.;
- White, Darrell;
- Chen, Christine I.;
- Sutherland, Heather J.;
- Madan, Sumit;
- LeBlanc, Richard;
- Sebag, Michael;
- Venner, Christopher P.;
- Bensinger, William I.;
- Biran, Noa;
- DeCastro, Andrew;
- Van Domelen, Dane R.
Publication type:
Article
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database.
Published in:
EJHaem, 2022, v. 3, n. 4, p. 1252, doi. 10.1002/jha2.559
By:
- McCurdy, Arleigh;
- Louzada, Martha;
- Venner, Christopher P.;
- Visram, Alissa;
- Masih‐Khan, Esther;
- Kardjadj, Moustafa;
- Jimenez‐Zepeda, Victor H.;
- LeBlanc, Richard;
- Sebag, Michael;
- Song, Kevin;
- White, Darrell;
- Mian, Hira;
- Stakiw, Julie;
- Reiman, Anthony;
- Aslam, Muhammad;
- Kotb, Rami;
- Gul, Engin;
- Reece, Donna
Publication type:
Article
High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors: The Alberta experience.
Published in:
Canadian Urological Association Journal, 2024, v. 18, n. 3, p. E73, doi. 10.5489/cuaj.8493
By:
- Hanbo Zhang;
- Alimohamed, Nimira S.;
- Basappa, Naveen S.;
- Cheng, Tina;
- Chu, Michael;
- Cox-Kennett, Nanette;
- Ernst, D. Scott;
- Fontaine, Amelie;
- Ghosh, Sunita;
- Heng, Daniel Y. C.;
- Littleton, Richard;
- North, Scott;
- Railton, Cindy;
- Sandhu, Irwindeep;
- Stenson, Trevor H.;
- Stewart, Douglas A.;
- Venner, Christopher P.;
- Venner, Peter;
- Kolinsky, Michael P.
Publication type:
Article

Found: 35